These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27623032)

  • 1. Flexible vs Rigid Epitope Conformations for Diagnostic- and Vaccine-Oriented Applications: Novel Insights from the Burkholderia pseudomallei BPSL2765 Pal3 Epitope.
    Gori A; Peri C; Quilici G; Nithichanon A; Gaudesi D; Longhi R; Gourlay L; Bolognesi M; Lertmemongkolchai G; Musco G; Colombo G
    ACS Infect Dis; 2016 Mar; 2(3):221-30. PubMed ID: 27623032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting the Burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology.
    Gourlay LJ; Peri C; Ferrer-Navarro M; Conchillo-Solé O; Gori A; Rinchai D; Thomas RJ; Champion OL; Michell SL; Kewcharoenwong C; Nithichanon A; Lassaux P; Perletti L; Longhi R; Lertmemongkolchai G; Titball RW; Daura X; Colombo G; Bolognesi M
    Chem Biol; 2013 Sep; 20(9):1147-56. PubMed ID: 23993463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK.
    Gourlay LJ; Thomas RJ; Peri C; Conchillo-Solé O; Ferrer-Navarro M; Nithichanon A; Vila J; Daura X; Lertmemongkolchai G; Titball R; Colombo G; Bolognesi M
    FEBS J; 2015 Apr; 282(7):1319-33. PubMed ID: 25645451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence- and Structure-Based Immunoreactive Epitope Discovery for Burkholderia pseudomallei Flagellin.
    Nithichanon A; Rinchai D; Gori A; Lassaux P; Peri C; Conchillio-Solé O; Ferrer-Navarro M; Gourlay LJ; Nardini M; Vila J; Daura X; Colombo G; Bolognesi M; Lertmemonkolchai G
    PLoS Negl Trop Dis; 2015; 9(7):e0003917. PubMed ID: 26222657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.
    Swetha RG; Sandhya M; Ramaiah S; Anbarasu A
    J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of a B cell antigen from B. pseudomallei.
    Gaudesi D; Peri C; Quilici G; Gori A; Ferrer-Navarro M; Conchillo-Solé O; Thomas R; Nithichanon A; Lertmemongkolchai G; Titball R; Daura X; Colombo G; Musco G
    ACS Chem Biol; 2015 Mar; 10(3):803-12. PubMed ID: 25495888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structure-based strategy for epitope discovery in Burkholderia pseudomallei OppA antigen.
    Lassaux P; Peri C; Ferrer-Navarro M; Gourlay LJ; Gori A; Conchillo-Solé O; Rinchai D; Lertmemongkolchai G; Longhi R; Daura X; Colombo G; Bolognesi M
    Structure; 2013 Jan; 21(1):167-175. PubMed ID: 23159127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse vaccinology and subtractive genomics-based putative vaccine targets identification for Burkholderia pseudomallei Bp1651.
    Hizbullah ; Nazir Z; Afridi SG; Shah M; Shams S; Khan A
    Microb Pathog; 2018 Dec; 125():219-229. PubMed ID: 30243554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.
    Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH
    J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of peptide mimotopes of Burkholderia pseudomallei exopolysaccharide.
    Legutki JB; Nelson M; Titball R; Galloway DR; Mateczun A; Baillie LW
    Vaccine; 2007 Nov; 25(45):7796-805. PubMed ID: 17935838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis.
    Gilmore G; Barnes J; Ketheesan N; Norton R
    Clin Vaccine Immunol; 2007 Nov; 14(11):1529-31. PubMed ID: 17804613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.
    Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS
    Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkholderia thailandensis whole cell antigen cross-reacts with B. pseudomallei antibodies from patients with melioidosis in an immunofluorescent assay.
    Puthucheary SD; Anuar AS; Tee TS
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):395-400. PubMed ID: 20578523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei.
    Muruato LA; Tapia D; Hatcher CL; Kalita M; Brett PJ; Gregory AE; Samuel JE; Titball RW; Torres AG
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28903988
    [No Abstract]   [Full Text] [Related]  

  • 15. Melioidosis patient serum-reactive synthetic tetrasaccharides bearing the predominant epitopes of Burkholderia pseudomallei and Burkholderia mallei O-antigens.
    Cloutier M; Delar E; Muru K; Ndong S; Hoyeck RR; Kaewarpai T; Chantratita N; Burtnick MN; Brett PJ; Gauthier C
    Org Biomol Chem; 2019 Oct; 17(39):8878-8901. PubMed ID: 31513223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel multi-component vaccine approaches for Burkholderia pseudomallei.
    Morici L; Torres AG; Titball RW
    Clin Exp Immunol; 2019 May; 196(2):178-188. PubMed ID: 30963550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice.
    Chin CY; Tan SC; Nathan S
    Front Cell Infect Microbiol; 2012; 2():85. PubMed ID: 22919676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses of selected phagotopes from monoclonal antibodies of Burkholderia pseudomallei.
    Na-ngam N; Kalambaheti T; Ekpo P; Pitaksajjakul P; Jamornthanyawat N; Chantratita N; Sirisinha S; Thamlikitkul V; Chaicumpa W; Yamabhai M; Ramasoota P
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):443-51. PubMed ID: 18564683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
    Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combating the great mimicker: latest progress in the development of
    Khakhum N; Chapartegui-González I; Torres AG
    Expert Rev Vaccines; 2020 Jul; 19(7):653-660. PubMed ID: 32669008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.